1. Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial. Issue 10366 (26th November 2022) Authors: Goodall, Ruth L; Meredith, Sarah K; Nunn, Andrew J; Bayissa, Adamu; Bhatnagar, Anuj K; Bronson, Gay; Chiang, Chen-Yuan; Conradie, Francesca; Gurumurthy, Meera; Kirenga, Bruce; Kiria, Nana; Meressa, Daniel; Moodliar, Ronelle; Narendran, Gopalan; Ngubane, Nosipho; Rassool, Mohammed; Sanders, Karen;... Journal: Lancet Issue: Volume 400:Issue 10366(2022) Page Start: 1858 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗